Sustained Overall Survival Benefit with Lenalidomide Plus Dexamethasone Versus No Treatment in Patients with Smoldering Myeloma at High Risk of Progression to Myeloma: Long Term Analysis
Blood (2016) 128 (22): 3308.
Currently there are no citedby results. Try again later.
